David Amsellem

David Amsellem is a seasoned financial professional with extensive experience in institutional equity research, particularly within the biotechnology and pharmaceutical sectors. Currently, as Managing Director and Senior Research Analyst at Piper Sandler since September 2008, David publishes research on a diverse range of biopharmaceutical companies, including AMGN, TEVA, and BIIB. Prior to this role, David served as Vice President at FBR from July 2003 to July 2008, where research focused on emerging specialty pharmaceutical companies. David also held roles as a Research Associate and Associate at Prudential Vector Healthcare and as an Analyst at Salomon Smith Barney. David holds a Bachelor of Science degree from Cornell University, earned in 1998.